US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Completed

TUMS Antacid

Reason Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.

GlaxoSmithKline Consumer Healthcare Holdings LLC D-0077-2024
Class II · Moderate risk Completed

TUMS Antacid

Reason Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.

GlaxoSmithKline Consumer Healthcare Holdings LLC D-0076-2024
Class II · Moderate risk Completed

TUMS Antacid

Reason Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.

GlaxoSmithKline Consumer Healthcare Holdings LLC D-0075-2024
Class II · Moderate risk Completed

TUMS Antacid

Reason Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.

GlaxoSmithKline Consumer Healthcare Holdings LLC D-0074-2024
Class II · Moderate risk Completed

TUMS Antacid

Reason Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.

GlaxoSmithKline Consumer Healthcare Holdings LLC D-0073-2024
Class I · High risk Terminated

Iohexol

Reason Labeling: Label Error on Declared Strength: syringes mislabeled as 300 mg iodine/mL contained product 350 mg iodine/mL

BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy D-0086-2023
Class II · Moderate risk Terminated

Oxcarbazepine Tablets 600mg

Reason Presence of foreign substance

Sun Pharmaceutical Industries INC NDC 62756-185-88 D-0085-2023
Class I · High risk Terminated

Daptomycin for Injection 350 mg/vial 1 Single-dose vial

Reason Labeling mixup: cartons labeled as Daptomycin 350 mg/vial were found to contain vials of Daptomycin 500 mg per vial

Accord Healthcare, Inc. NDC 16729-0434-05 D-0131-2023
Class II · Moderate risk Terminated

FentaNYL Citrate 2.5 mg/50 mL

Reason Underfilled units.

OurPharma LLC NDC 73013-001-01 D-0078-2023
Class I · High risk Terminated

8.4% Sodium Bicarbonate Injection

Reason Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.

Exela Pharma Sciences LLC NDC 72572-740-20 D-0080-2023
Class I · High risk Terminated

8.4% Sodium Bicarbonate Injection

Reason Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.

Exela Pharma Sciences LLC NDC 51754-5001-5 D-0079-2023
Class II · Moderate risk Terminated

Sensorcaine-MPF

Reason Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product.

Fresenius Kabi USA, LLC NDC 63323-468-01 D-0129-2023
Class II · Moderate risk Terminated

Sensorcaine

Reason Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product.

Fresenius Kabi USA, LLC NDC 63323-463-01 D-0128-2023
Class II · Moderate risk Terminated

Sensorcaine

Reason Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product.

Fresenius Kabi USA, LLC NDC 63323-461-01 D-0127-2023
Class II · Moderate risk Ongoing

0.9% Sodium Chloride Injection

Reason Lack of Assurance of Sterility: Leakage of 0.9% Sodium Chloride for Injection, 1L, 12pk Saline Solution.

Fresenius Medical Care Holdings, Inc. NDC 49230-300-10 D-0075-2023
Class III · Low risk Terminated

Allergy Relief D

Reason Failed dissolution specifications

Dr. Reddy's Laboratories, Inc. NDC 49032-273-20 D-0073-2023
Class II · Moderate risk Ongoing

Daytrana

Reason Defective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal patches.

Noven Pharmaceuticals Inc NDC 68968-5553-3 D-0071-2023
Class III · Low risk Terminated

Sodium Sulfacetamide 10% Sulfur 4% Cleansing Pads

Reason Subpotent drug: Out of specification for assay at the end-of-shelf-life 24-month period.

Acella Pharmaceuticals, LLC NDC 42192-113-60 D-0074-2023
Class III · Low risk Terminated

Phenytoin Sodium Injection

Reason Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.

Acella Pharmaceuticals, LLC NDC 42192-614-05 D-0070-2023
Class III · Low risk Terminated

Phenytoin Sodium Injection

Reason Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.

Acella Pharmaceuticals, LLC NDC 42192-614-02 D-0069-2023
Class II · Moderate risk Terminated

PF-Neostigmine Methylsulfate Injection

Reason CGMP Deviations: Potential for cross contamination due to product carry over.

Nephron Sterile Compounding Center LLC NDC 69374-932-33 D-0065-2023
Class II · Moderate risk Terminated

PF-Labetalol HCl Injection

Reason CGMP Deviations: Potential for cross contamination due to product carry over.

Nephron Sterile Compounding Center LLC NDC 69374-946-34 D-0064-2023
Class II · Moderate risk Terminated

Phenoxybenzamine Hydrochloride Capsules

Reason Failed Impurities/Degradation Specifications

Par Formulations Private Limited NDC 49884-038-01 D-0061-2023